Evidence map›Paper›PMID 40285478›Full record

ArticleInflammatory bowel diseases2025

Risk Factors for Chronic Kidney Disease in Patients With Crohn's Disease.

Andres Rodriguez, Maria Alejandra Quintero, Hajar Hazime, Rose Killian, Gloria Michelle Ducasa, Katerina M Faust, Maria T Abreu

Abstract read
In one paragraph

Article in Inflammatory bowel diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andres RodriguezDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Maria Alejandra QuinteroUHealth Crohn's & Colitis Center, Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami School of Medicine, Miami, FL, USA.
Hajar HazimeUHealth Crohn's & Colitis Center, Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami School of Medicine, Miami, FL, USA.
Rose KillianJohn P. Hussman Institute for Human Genomics, University of Miami, Miami, FL, USA.
Gloria Michelle DucasaDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Katerina M FaustUHealth Crohn's & Colitis Center, Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami School of Medicine, Miami, FL, USA.
Maria T AbreuUHealth Crohn's & Colitis Center, Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami School of Medicine, Miami, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with inflammatory bowel diseases (IBD), including Crohn's disease (CD), are at risk of complications, including kidney disease. It is important to identify IBD patients at higher risk of chronic kidney disease (CKD) to improve prevention and treatment. Here, we investigated the clinical and metabolomic characteristics of CD patients who develop CKD.

methodsWe identified adult CD patients with (CD + CKD, n = 87) and selected CD patients without CKD (CD controls) matched by age, race, and gender. We collected data on demographic characteristics (age, smoking status, ethnicity, gender), IBD characteristics (diagnosis, Montreal classification, medication use, IBD-related surgeries, perianal disease), and kidney-related factors (primary sclerosing cholangitis, end-stage renal disease, hypertension, diabetes, organ transplantation, and nephrolithiasis). Univariate and multivariate analyses were conducted and odds ratios were calculated to identify risk factors for CKD. Serum samples were collected for untargeted metabolomic analysis.

resultsChronic kidney disease was far more common in CD patients than UC patients. Crohn's disease patients with kidney stones had a 10-fold higher risk of developing CKD than those without kidney stones. Crohn's disease patients with more than 2 IBD-related surgeries had a 7.3-fold higher risk of developing CKD than those who had not undergone surgery. There was no relationship between the number of biologics used or mesalamine use and the risk of CKD. The serum of CD + CKD patients had elevated levels of pro-inflammatory metabolites and those linked to kidney injury.

conclusionsWe recommend regular kidney function monitoring and ensuring proper hydration to prevent or manage potential kidney-related complications in CD patients. Patients with resections and kidney stones are particularly vulnerable.

Indexed as

Crohn DiseaseRenal Insufficiency, ChronicAdultCase-Control StudiesFemaleFollow-Up StudiesHumansMaleMetabolomicsMiddle AgedPrognosisRisk FactorsYoung Adultchronic kidney diseaseCrohn’s diseaseinflammatory bowel diseaserisk factors

Identifiers

PMID40285478
PMCPMC12558573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.